Old Web
English
Sign In
Acemap
>
Paper
>
125OPembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
125OPembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
2019
H.C. Chung
Y-J Bang
J. Tabernero
E. Van Cutsem
Charles S. Fuchs
Lucjan Wyrwicz
K-W Lee
I. Kudaba
Marcelo Garrido
Hugo Castro
Wasat Mansoor
Maria Ignez Braghiroli
Eray Goekkurt
Joseph Chao
Zev A. Wainberg
Uma Kher
Sukrut Shah
Kohei Shitara
Keywords:
Internal medicine
Oncology
Adenocarcinoma
General surgery
Chemotherapy
Medicine
Pembrolizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]